Transactions of the Royal Society of Tropical Medicine and Hygiene · 2026
Predictive value of platelet indices as early markers of mortality in patients with Crimean-Congo haemorrhagic fever: a retrospective observational study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
İnan Sarıkaya Rukiye, Yanık Ayten, Karaşahin Ömer
Аннотация
BACKGROUND: To evaluate the predictive value of admission platelet-related indices for in-hospital mortality in Crimean-Congo haemorrhagic fever (CCHF).
METHODS: This retrospective single-centre study included adults with laboratory-confirmed CCHF between May 2022 and May 2023. The primary outcome was in-hospital mortality. Admission laboratory parameters and platelet-related indices were analysed using receiver operating characteristics analysis, DeLong comparisons, 2000-replicate bootstrap internal validation and reduced Firth logistic regression adjusted for age.
RESULTS: A total of 167 patients (median age 47 y [interquartile range 34-62], 61.7% male) were included; 14 (8.4%) died. Non-survivors were older. Platelet count, platelet count multiplied by lymphocyte count (PLT×LYM) and plateletcrit were lower, whereas mean platelet volume:lymphocyte ratio, platelet distribution width:lymphocyte ratio and mean platelet volume:platelet count ratio were higher in non-survivors. Median PLT×LYM was lower in non-survivors than survivors (15.35 vs 49.56; p<0.001). PLT×LYM had the highest discriminatory performance (area under the curve 0.882, cut-off 39.33, sensitivity 100%, specificity 66.7%, positive predictive value 21.5%, negative predictive value 100.0%). In the logistic regression model, each 10-unit increase in PLT×LYM was associated with an adjusted odds ratio of 0.50 (95% confidence interval 0.30 to 0.73).
CONCLUSION: Admission PLT×LYM may serve as practical early marker for mortality risk stratification in CCHF; external validation is required.
METHODS: This retrospective single-centre study included adults with laboratory-confirmed CCHF between May 2022 and May 2023. The primary outcome was in-hospital mortality. Admission laboratory parameters and platelet-related indices were analysed using receiver operating characteristics analysis, DeLong comparisons, 2000-replicate bootstrap internal validation and reduced Firth logistic regression adjusted for age.
RESULTS: A total of 167 patients (median age 47 y [interquartile range 34-62], 61.7% male) were included; 14 (8.4%) died. Non-survivors were older. Platelet count, platelet count multiplied by lymphocyte count (PLT×LYM) and plateletcrit were lower, whereas mean platelet volume:lymphocyte ratio, platelet distribution width:lymphocyte ratio and mean platelet volume:platelet count ratio were higher in non-survivors. Median PLT×LYM was lower in non-survivors than survivors (15.35 vs 49.56; p<0.001). PLT×LYM had the highest discriminatory performance (area under the curve 0.882, cut-off 39.33, sensitivity 100%, specificity 66.7%, positive predictive value 21.5%, negative predictive value 100.0%). In the logistic regression model, each 10-unit increase in PLT×LYM was associated with an adjusted odds ratio of 0.50 (95% confidence interval 0.30 to 0.73).
CONCLUSION: Admission PLT×LYM may serve as practical early marker for mortality risk stratification in CCHF; external validation is required.